MDTrials SRL
The score of MDTrials shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MDTrials's annual accounts
| 2025 | |
|---|---|
| Net result | 55,859 € |
| Equity | 364,489 € |
| Cash | 53,355 € |
| EBITDA | 88,500 € |
| Total assets | 372,427 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 06 Jan 2026
MDTrials's financial analysis
- Solvency97.9%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDTrials
MDTrials's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0822.234.455
- VAT number
- BE0822234455
- Peppol
- Registered · 0208:0822234455 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jan 2010
- Registered office
- 8200 Bruges
- Latest accounts
- 2025 · filed on 06 Jan 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
MDTrials (SRL) has been based in Bruges since 2010, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 55,859 € and equity of 364,489 €; its revenue is not published. Its solvency stands at 97.9%, above the median of its sector (60.4%).
Companies similar to MDTrials
Companies in the same business, of comparable size and area, outside its group.
- CTTec Research and experimental development on natural sciences and engineering Menen · balance sheet 259,750 €
- Orineo Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 394,122 €
- Belma Technologies Research and experimental development on natural sciences and engineering Liège · balance sheet 281,040 €
- TRACKS&Co Research and experimental development on natural sciences and engineering Jurbise · balance sheet 528,835 €
- NorthboundBio Research and experimental development on natural sciences and engineering Leuven · balance sheet 286,592 €
- Semaphar Research and experimental development on natural sciences and engineering Jodoigne · balance sheet 579,404 €
- Hans DE Vilder - Clinical Research Consultancy Research and experimental development on natural sciences and engineering Genk · balance sheet 267,868 €
- Huisarts Nadine Costers Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 502,719 €
Frequently asked questions about MDTrials
What is the revenue of MDTrials?
MDTrials files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MDTrials?
In Belgium, the VAT number is the company number prefixed with BE: BE0822234455 for MDTrials, if the company is VAT-registered. Its company number (CBE) is 0822.234.455.
Where is the registered office of MDTrials?
According to the CBE register, the registered office of MDTrials is in 8200 Bruges.
What is the equity of MDTrials?
At the close of the 2025 financial year, the equity of MDTrials amounts to 364,489 €, a solvency of 97.9% of total assets.
Who manages MDTrials?
The register lists 1 active mandates at MDTrials. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MDTrials
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →